Three-drug combination remodels immune environment in gastric cancer

November 4, 2026

A triplet combination therapy can remodel the tumor microenvironment in patients with advanced gastric cancer and shows a promising safety profile, according to results from a new phase 2 clinical trial.

Search

RECENT PRESS RELEASES

Apple is reportedly cutting budgets for its internal AI usage

SWI Editorial Staff2026-11-04T17:26:22-08:00November 4, 2026|

Australian electric vehicle sales by month in 2026 – by model and by brand

SWI Editorial Staff2026-11-04T17:24:25-08:00November 4, 2026|

Tesla Giga Texas Reportedly Moves to Two 12-Hour Shifts Through Year End, But Joe Tegtmeyer’s Drone Shows Lots Already Full of New Cars

SWI Editorial Staff2026-11-04T17:18:27-08:00November 4, 2026|

Detroit voters react to Democratic wave in U.S. midterms

SWI Editorial Staff2026-11-04T17:16:36-08:00November 4, 2026|

Used EVs are selling fast as gas prices and car costs rise

SWI Editorial Staff2026-11-04T17:15:52-08:00November 4, 2026|

EU and UK must deepen partnership or lose ground in global automotive race, new LSE Consul

SWI Editorial Staff2026-11-04T17:01:00-08:00November 4, 2026|